Despite 8 straight beats with revenues growing high-single to low-double digits, COO's share price continues to whipsaw in 2018.
CooperVision and CooperSurgical have together added 6 new businesses as its aggressive strategies look to rival its stronger competitors in Alcon and Johnson & Johnson.
The addition of a $1.425 loan agreement to support its acquisition of PARAGARD sees total debt doubled from the previous quarter.
On June 7th, 2018, The Cooper Companies (COO) will report its fiscal second-quarter earnings. The mid-cap healthcare device company has seen whipsaw movement in stock price so far in 2018. At the beginning